Jon Moulton assesses bids for the Regional Growth Fund, which assisted Redx Pharma, a pharmaceutical in which he has a 26 per cent stake Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,